Literature DB >> 9950160

Interstitial foam cells and oxidized lipoprotein in human glomerular disease.

A B Magil1.   

Abstract

Foam cells (FCs) have been detected in the cortical interstitium of some patients with glomerular disease. Whether they have a significant role in tubulointerstitial injury and disease progression is uncertain. Renal biopsy specimens from 13 patients with glomerular disease (6 with Alport's syndrome, 5 with focal glomerulosclerosis, 2 with membranoproliferative glomerulonephritis, Type 1) showing interstitial FCs were investigated by histochemical means for neutral lipid (oil red O stain); immunohistochemical means for monocytes/macrophages (CD68), apolipoproteins (Apo) A-I, B, and E, and oxidized low-density lipoprotein (LDL); and by electron microscopic examination. FCs were positive for neutral lipid, CD68, and oxidized lipoprotein but did not stain for Apo B. In four specimens, there was a weak FC reaction for Apo E alone and in one case for both Apo E and Apo A-I. Focal interstitial staining was observed for both Apo B and E but not for Apo A-I. There was focal staining of tubular epithelial cytoplasm for neutral lipid in all of the specimens, for Apo E in five of seven specimens, for oxidized lipoprotein in case, and for Apo A-I in three cases. Electron microscopic analysis showed that the FC contained numerous clear cytoplasmic vacuoles that were not membrane-bound and that were generally associated with increased numbers of collagen fibrils and basement membrane-like extracellular matrix and frequently with aggregates of extracellular lipid-like particles embedded in extracellular matrix. The findings are analogous to those in atherosclerosis and suggest a role for FCs and oxidized lipoprotein in the pathogenesis of interstitial injury in some cases of glomerular disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950160

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  5 in total

1.  Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment.

Authors:  J W Knowles; R L Reddick; J C Jennette; E G Shesely; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Hypertensive renal disease: susceptibility and resistance in inbred hypertensive rat lines.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; M John Hicks; Scott E Wenderfer; Peter A Doris
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

3.  Bardoxolone methyl decreases megalin and activates nrf2 in the kidney.

Authors:  Scott A Reisman; Glenn M Chertow; Sudarshan Hebbar; Nosratola D Vaziri; Keith W Ward; Colin J Meyer
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

4.  Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults.

Authors:  Fei Huang; Le Wang; Qian Zhang; Zhengce Wan; Liu Hu; Ranran Xu; Anying Cheng; Yongman Lv; Qingquan Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

5.  The effect of triglycerides to high-density lipoprotein cholesterol ratio on the reduction of renal function: findings from China health and retirement longitudinal study (CHARLS).

Authors:  Shiqi Lv; Han Zhang; Jing Chen; Ziyan Shen; Cheng Zhu; Yulu Gu; Xixi Yu; Di Zhang; Yulin Wang; Xiaoqiang Ding; Xiaoyan Zhang
Journal:  Lipids Health Dis       Date:  2021-09-20       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.